DNA Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own DNA shares is 223, representing 67.65% of the company's common stock.

STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM, in the last quarter, reduced its stake in DNA by -33.31% restricting it's holding to 528.77 thousand shares of worth nearly $703.26K. NORTHERN TRUST CORP also lessened -2.91% of the DNA shares from its portfolio, reducing its holding to 5.97 million shares of worth $6.92M. NORDEA INVESTMENT MANAGEMENT AB also shunned DNA shares holding by -0.95% last quarter which brought its holding to 4.37 million shares worth $5.18M.

As per its latest 13F filing, LEGAL & GENERAL GROUP PLC increased its stake in DNA by 628.16% in the last quarter. The institutional holder raised its holding to 11.44 million shares having worth more than $13.37M. MILLENNIUM MANAGEMENT LLC also added 14.12% more shares of DNA to its portfolio, raising its holding to 10.58 million shares of worth $12.27M. EXOR CAPITAL LLP also increased its DNA shares holding by 17.62% which brought its holding to 10.01 million shares worth $11.61M.

The insider with the most stakes in DNA is Canton Barry , 10 percent owner at the company. Additionally, DNA stock is highly held by See remarks Shetty Reshma P. and director DEKKERS MARIJN E among others.

Company executives, directors, and other insiders own 6.68% percent of Ginkgo Bioworks Holdings, Inc.'s stock. Within the last six months, there have been 10 transaction(s) in which DNA insiders have sold stock, totaling 6.68K shares. Insiders that have sold shares include DMYTRUK MARK E., COEN STEVEN P., and DEKKERS MARIJN E.

There have been 0 transaction(s) during the past 6-months in which Ginkgo Bioworks Holdings, Inc. insiders have bought stock, totalling 0 shares

Around 188.47K Ginkgo Bioworks Holdings, Inc. shares are held by insiders, which represents about 6.68% of DNA stock.

DNA 10 percent owner, Canton Barry holds the largest portfolio of the company's shares. DNA shares owned by Canton total nearly 12.37 million.

LEGAL & GENERAL GROUP PLC is the largest institutional owner in DNA which holds 11.44 million shares worth $13.37M or 0.59% of the total DNA shares outstanding followed by STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM with ownership of 528.77 thousand shares representing 0.03% of the DNA ownership. TD ASSET MANAGEMENT INC is the third largest stakeholder with 521.85 thousand shares or 0.03% of the ownership worth more than $605.35M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the DNA is concerned, it is a stock which is optionable.

Number of DNA shares short is 7.37M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 45.20M shares of DNA are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, DNA has 32.96M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for DNA is 4.88.